Articles Archives - Page 2 of 751

FridayNov 21, 2025 9:00 am

Forward Industries Inc. (NASDAQ: FWDI) Changes NASDAQ Ticker Symbol Following Recent Company Milestones

Forward Industries recently changed the company’s stock ticker from FORD to FWDI. The ticker change reflects the company’s strategic focus on being the leading Solana (SOL) treasury, by both acquiring more SOL and increasing SOL-per-share by actively participating in the SOL ecosystem. This also follows a number of company milestones including reaching total holdings of over 6.9 million SOL and forming a strong crypto advisory board. Forward Industries (NASDAQ: FWDI), a Solana (SOL) treasury company, recently changed the company’s NASDAQ ticker symbol from FORD to FWDI (https://ibn.fm/RdFKy). The move reflects Forward Industries’ focus on the company’s SOL treasury strategy. This…

WednesdayNov 19, 2025 10:30 am

GlobalTech Corp. (GLTK) Is Building Scalable Tech Platforms and Has a Diverse Portfolio of AI-Powered Solutions, including Cadnz

Committed to acquiring companies with strong potential, developing and scaling these assets across a variety of industries Among the company’s portfolio is Cadnz, a leading automation platform for the financial services industry Recently, the founder and CEO of Cadnz, Imran Riaz, sat down for an interview where he spoke about his vision for Cadnz, as well as how automation, data intelligence, and smart integrations are reshaping digital lending for banks and credit unions in the U.S. GlobalTech (OTC: GLTK) is a technology holding company that focuses on acquiring and building scalable tech platforms in areas like big data, AI and…

WednesdayNov 19, 2025 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Posts Record Nine-Month Net Income as Electronic Monitoring Contracts Accelerate Across Global Markets

SuperCom has reported record net income of $6 million for the first nine months of 2025, more than doubling the prior year. Gross margin expanded to 61%, while EBITDA reached $7.2 million, reflecting improved operating leverage and higher-margin contracts. Q3 results showed continued momentum, including non-GAAP net income of $1.9 million and an EBITDA margin of 34.6%. Since mid-2024, the company has secured over 30 new U.S. electronic monitoring contracts and entered 13 new states, frequently displacing incumbent providers. International expansion included a $7 million national contract in Germany, its second major European win in as many years. SuperCom’s PureSecurity(TM)…

WednesdayNov 19, 2025 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) CEO Notes Company IS Poised to Reinforce North America’s Rare-Earth Supply Chain

Disseminated on behalf of  Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. During interview, Ryan framed rare earths not just as mined commodities but as elements of control. Ucore’s strategy features a dual-node approach, with facilities on both Canada and the United States. The company’s refining technology is designed to fill critical downstream gaps in the rare-earth value chain. In a recent interview with InvestorNews, Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) CEO Pat Ryan emphasized the strategic urgency of building a sovereign Western supply chain for rare earth elements, identifying samarium as “the most…

TuesdayNov 18, 2025 9:45 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Starts Confirmation Drilling Program in Val-d’Or Gold Belt to Validate Historical Results at Swanson

This article has been disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising. LaFleur Minerals, Canadian gold exploration and development company, just launched a confirmation drilling program at its Swanson Gold Deposit in Val-D’Or, Quebec, supporting a Preliminary Economic Assessment (“PEA”) for the restart of gold production at the company's Beacon Gold Mill The campaign will work to validate historical results on the property while improving confidence in the geological model of the area The 10-hole twinned-drilling campaign will supply fresh core for ore-sorting and metallurgical test work, with the data feeding…

TuesdayNov 18, 2025 9:00 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Is ‘One to Watch’

This article has been disseminated on behalf of  Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax is advancing three core rare earth exploration projects across North America, each located in established mining districts with strong infrastructure and regulatory support. The Atikokan Project has confirmed district-scale REE anomalies through integrated geochemical, geophysical, and structural analysis. The Cameron Project in British Columbia has demonstrated both light and heavy REE enrichment, indicating potential for significant surface-accessible mineralization. The Ogden Bear Lodge Project provides strategic exposure to a U.S. REE district supported by DOE and EXIM initiatives. With experienced…

MondayNov 17, 2025 9:45 am

Safe & Green Holdings Corp. (NASDAQ: SGBX) Sets December 29 Annual Meeting as It Advances Energy Strategy and Finalizes Olenox–Safe & Green Merger

The energy-focused holding company has scheduled its 2025 Annual Meeting of Stockholders for December 29, 2025, with a record date of November 21. A key agenda item is shareholder approval enabling the former shareholders of New Asia Holdings to convert preferred shares into common stock, completing the second phase of the Olenox–Safe & Green merger. The company is formally shifting away from modular construction to become an integrated energy enterprise, centered on Olenox’s oil, gas, services, and technologies divisions. Olenox is launching an aggressive drilling program beginning in Q4 2025, with ambitions to reach 1,000 BOE/day by the end of…

MondayNov 17, 2025 9:00 am

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Driving Alaska’s Mining Resurgence, Unlocking Critical Minerals at the Ambler Mining District

Federal permitting for the Ambler Access Project supports future access to Alaska’s copper-rich Ambler Mining District, where Trilogy Metals is strategically positioned for development Trilogy's Upper Kobuk Mineral Projects (“UKMP”) in the Ambler Mining District strategically position America in its quest for stable, domestic supplies for critical minerals With the rise of Alaska’s resource sector, the company is at the forefront of sustainable infrastructure expansion, growth, and energy security This article has been disseminated on behalf of  Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ), a company at…

FridayNov 14, 2025 10:30 am

Federal Permits to Advance Ambler Access Project Strengthen Alaska’s Role in Domestic Supply Chain of Critical Minerals

Trilogy Metals is advancing one of North America’s richest undeveloped districts through its 50% joint venture with South32 Limited Of the U.S. government’s 60 designated critical minerals, at least 50 are found within the state of Alaska The company operates at the intersection of critical minerals, mineral exploration potential and U.S. energy transition policy This article has been disseminated on behalf of  Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. As the global demand for metals surges and the U.S. government turns to Alaska for secure critical mineral supply, a renewed sense of purpose is…

FridayNov 14, 2025 9:45 am

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Targets Glioblastoma with Innovative Therapies, Addressing One of Oncology’s Greatest Unmet Needs

Glioblastoma multiforme (“GBM”) is an aggressive brain cancer with limited treatment options, and CEO John Climaco emphasized the company’s commitment to overcoming the blood-brain barrier, a key obstacle in brain cancer therapy. Lead candidate TPI 287, an abeotaxane, has shown early evidence of appearing to cross the blood-brain barrier and producing clinical responses. Phase 2 planning is underway following encouraging data from a Phase 1 combination study with bevacizumab (Avastin). The company’s repurposed global clinical network and regulatory progress position it for potential late-stage development in 2026. TPI 287 holds multiple Orphan Drug Designations, covering gliomas, neuroblastoma, and other CNS-related…

Site Search

Company Search

Category: Articles